Journal of Basic and Clinical Physiology and Pharmacology · 1995 · 15 citations · 9 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyEpilepsyEpileptologyAntiepileptic PharmacologyAntiepileptic PharmacotherapyCopper DeficiencyEpilepsy In ChildhoodZinc DeficiencyAntiepileptic Drug EfficacyCombination TherapyMetal Homeostasis RegulationMetal Ion HomeostasisPediatric Antiepileptic TherapySerum Zinc BiomarkersTrace Metal HomeostasisValproic Acid
The results of previous studies that examined serum trace metal status of epileptic patients receiving antiepileptic drug (AED) therapy were variable. We measured serum zinc (Zn) and copper (Cu) levels in 52 epileptic children who were treated with either carbamazepine (CBZ) or valproic acid (VPA) or with a combination of CBZ and VPA. Serum Zn levels were significantly lower in the epileptics than in the two control groups which consisted of 7 untreated epileptics and 12 normal children (p < 0.05). Combination therapy and monotherapy with CBZ increased serum Cu levels (p < 0.05). No significant alteration in serum Cu levels was observed with VPA monotherapy. Serum Zn and serum Cu concentrations of the untreated epileptics were not significantly different from those of normal controls. Our results indicate that serum trace metal homeostasis may be affected by AED therapy, but not by the convulsive disorder itself.
9
Selenium, zinc, and copper changes with valproic acid
Russell W. Hurd, H.A. Van Rinsvelt, B. J. Wilder et al. · Neurology · 1984 · 65 citations
Pharmacy, Pharmacology, Toxicology +15
Serum Copper and Zinc Levels in Epileptic Children with Valproate Treatment
Masayuki Kaji, Masatoshi Ito, Takehiko Okuno et al. · Epilepsia · 1992 · 37 citations
Medicine, Neurology, Pharmacotherapy +14
Hypercupraemia Induced by Antiepileptic Drugs
Karabi Ghose, Andrew Taylor · Human Toxicology · 1983 · 21 citations